Complete Genomics Books Orders for More than 500 Human Genomes; Eli Lilly Among New Customers | GenomeWeb

By Julia Karow

This story was originally published on February 22, 2010.

Six months after disclosing some of its first early-access customers for its human whole-genome sequencing service, Complete Genomics said this week that it has booked orders for a total of more than 500 human genomes from more than 30 customers, including three projects that comprise at least 100 genomes each. New customers include academic research groups as well as pharma giant Eli Lilly.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.